Left Ventricular Assist Device Emergencies: Diagnosis and Management

Susie Sennhauser; Lakshmi Sridharan

doi:10.1016/j.ccc.2023.06.004

Left Ventricular Assist Device Emergencies: Diagnosis and Management

Crit Care Clin. 2024 Jan;40(1):159-177. doi: 10.1016/j.ccc.2023.06.004. Epub 2023 Jul 19.

Authors

Susie Sennhauser¹, Lakshmi Sridharan²

Affiliations

¹ Division of Cardiology, Department of Medicine, Emory University School of Medicine.
² Division of Cardiology, Department of Medicine, Emory University School of Medicine. Electronic address: lakshmi.sridharan@emory.edu.

PMID: 37973352
DOI: 10.1016/j.ccc.2023.06.004

Abstract

Durable left ventricular assist devices (LVADs) are a virtually limitless advanced therapy option for an increasingly growing population of patients with end-stage advanced heart failure. As of 2019, 30% to 40% of all patients diagnosed with heart failure were categorized as New York Heart Association class III or IV. In 2018 more than 3.2 million office visits and 1.4 million emergency department visits carried a primary diagnosis of heart failure. Given the rapid growth of the LVAD population, facility in the diagnosis and management of common perioperative and outpatient LVAD emergencies has become of paramount importance in a variety of clinical settings.

Keywords: Alarms; Complications; Left ventricular assist devices (LVAD); Management; Mechanical circulatory support device (MCSD).

Publication types

Review

MeSH terms

Emergencies
Heart Failure* / diagnosis
Heart Failure* / therapy
Heart-Assist Devices* / adverse effects
Humans